Exosome Research Solutions

About GeneCopoeia

GeneCopoeia is a privately held, revenue-generating provider of essential research tools for the biotechnology and pharmaceutical sectors. Operating as a platform and services business, it supplies high-quality, sequence-verified reagents such as ORF clones, lentiviruses, and stable cell lines to accelerate basic and translational research. The company has strategically expanded its portfolio into high-growth areas like immuno-oncology, exosome research, and COVID-19 tools, positioning itself as a one-stop shop for academic and industrial researchers. Its core value proposition is built on guaranteed sequence accuracy and a broad, integrated product ecosystem.